Q&A: PhRMA CEO Stephen Ubl on the IRA, challenges to the FDA’s authority and the US-China relationship

As we ap­proach the 2024 pres­i­den­tial elec­tion, Stephen Ubl, pres­i­dent and CEO of the phar­ma­ceu­ti­cal in­dus­try’s DC-based trade group PhRMA, said “the po­lit­i­cal process has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.